Authors:
OSTERHAUS ADME
VOS MC
BALK AHMM
DEMAN RA
MOUTON JW
ROTHBARTH PH
SCHALM SW
TOMAELLO AM
NIESTERS HGM
VERBRUGH HA
Citation: Adme. Osterhaus et al., TRANSMISSION OF HEPATITIS-B VIRUS AMONG HEART-TRANSPLANT RECIPIENTS DURING ENDOMYOCARDIAL BIOPSY PROCEDURES, The Journal of heart and lung transplantation, 17(2), 1998, pp. 158-166
Authors:
VANTVEEN A
WOLLMER P
NILSSON LE
GOMMERS D
MOUTON JW
KOOIJ PPM
LACHMANN B
Citation: A. Vantveen et al., LUNG DISTRIBUTION OF INTRATRACHEALLY INSTILLED TC-99M-TOBRAMYCIN-SURFACTANT MIXTURE IN RATS WITH A KLEBSIELLA-PNEUMONIAE LUNG INFECTION, ACP. Applied cardiopulmonary pathophysiology, 7(2), 1998, pp. 87-94
Authors:
DEMARIE S
VANDENBERGH MFQ
BUIJK SLCE
BRUINING HA
VANVLIET A
KLUYTMANS JAJW
MOUTON JW
Citation: S. Demarie et al., BIOAVAILABILITY OF CIPROFLOXACIN AFTER MULTIPLE ENTERAL AND INTRAVENOUS DOSES IN ICU PATIENTS WITH SEVERE GRAM-NEGATIVE INTRAABDOMINAL INFECTIONS, Intensive care medicine, 24(4), 1998, pp. 343-346
Authors:
VERBRUGGE SJC
SORUM V
VANTVEEN A
MOUTON JW
GOMMERS D
LACHMANN B
Citation: Sjc. Verbrugge et al., LUNG OVERINFLATION WITHOUT POSITIVE END-EXPIRATORY PRESSURE PROMOTES BACTEREMIA AFTER EXPERIMENTAL KLEBSIELLA-PNEUMONIAE INOCULATION, Intensive care medicine, 24(2), 1998, pp. 172-177
Citation: Hla. Vandenoever et al., CIPROFLOXACIN IN PRETERM NEONATES - CASE-REPORT AND REVIEW OF THE LITERATURE, European journal of pediatrics, 157(10), 1998, pp. 843-845
Citation: Jg. Denhollander et al., USE OF PHARMACODYNAMIC PARAMETERS TO PREDICT EFFICACY OF COMBINATION THERAPY BY USING FRACTIONAL INHIBITORY CONCENTRATION KINETICS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 744-748
Authors:
DENHOLLANDER JG
FUURSTED K
VERBRUGH HA
MOUTON JW
Citation: Jg. Denhollander et al., DURATION AND CLINICAL RELEVANCE OF POSTANTIBIOTIC EFFECT IN RELATION TO THE DOSING INTERVAL, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 749-754
Authors:
DENHOLLANDER JG
KNUDSEN JD
MOUTON JW
FUURSTED K
FRIMODTMOLLER N
VERBRUGH HA
ESPERSEN F
Citation: Jg. Denhollander et al., COMPARISON OF PHARMACODYNAMICS OF AZITHROMYCIN AND ERYTHROMYCIN IN-VITRO AND IN-VIVO, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 377-382
Citation: Jn. Vandenanker et al., DO WE NEED THERAPEUTIC DRUG-MONITORING OF TOBRAMYCIN IN THE NEWBORN-INFANT, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 82-82
Authors:
RENDERS NHM
SIJMONS MAF
VANBELKUM A
OVERBEEK SE
MOUTON JW
VERBRUGH HA
Citation: Nhm. Renders et al., EXCHANGE OF PSEUDOMONAS-AERUGINOSA STRAINS AMONG CYSTIC-FIBROSIS SIBLINGS, Research in microbiology, 148(5), 1997, pp. 447-454
Authors:
MOUTON JW
ENDTZ HP
DENHOLLANDER JG
VANDENBRAAK N
VERBRUGH HA
Citation: Jw. Mouton et al., IN-VITRO ACTIVITY OF QUINUPRISTIN DALFOPRISTIN COMPARED WITH OTHER WIDELY USED ANTIBIOTICS AGAINST STRAINS ISOLATED FROM PATIENTS WITH ENDOCARDITIS/, Journal of antimicrobial chemotherapy, 39, 1997, pp. 75-80
Authors:
VANDUYNHOVEN YTHP
VANDELAAR MJW
SCHOP WA
MOUTON JW
VANDERMEIJDEN WI
SPRENGER MJW
Citation: Ythp. Vanduynhoven et al., DIFFERENT DEMOGRAPHIC AND SEXUAL CORRELATES FOR CHLAMYDIAL INFECTION AND GONORRHEA IN ROTTERDAM, International journal of epidemiology, 26(6), 1997, pp. 1373-1385
Authors:
MOUTON JW
VERKOOYEN R
VANDERMEIJDEN WI
VANRIJSOORTVOS TH
GOESSENS WHF
KLUYTMANS JAJW
DEELEN SDA
LUIJENDIJK A
VERBRUGH HA
Citation: Jw. Mouton et al., DETECTION OF CHLAMYDIA-TRACHOMATIS IN MALE AND FEMALE URINE SPECIMENSBY USING THE AMPLIFIED CHLAMYDIA-TRACHOMATIS TEST, Journal of clinical microbiology, 35(6), 1997, pp. 1369-1372
Authors:
GOESSENS WHF
MOUTON JW
VANDERMEIJDEN WI
DEELEN S
VANRIJSOORTVOS TH
TOOM NLD
VERBRUGH HA
VERKOOYEN RP
Citation: Whf. Goessens et al., COMPARISON OF 3 COMMERCIALLY AVAILABLE AMPLIFICATION ASSAYS, AMP CT, LCX, AND COBAS AMPLICOR, FOR DETECTION OF CHLAMYDIA-TRACHOMATIS IN FIRST-VOID URINE, Journal of clinical microbiology, 35(10), 1997, pp. 2628-2633
Authors:
ENDTZ HP
MOUTON JW
DENHOLLANDER JG
VANDENBRAAK N
VERBRUGH HA
Citation: Hp. Endtz et al., COMPARATIVE IN-VITRO ACTIVITIES OF TROVAFLOXACIN (CP-99,219) AGAINST 445 GRAM-POSITIVE ISOLATES FROM PATIENTS WITH ENDOCARDITIS AND THOSE WITH OTHER BLOOD-STREAM INFECTIONS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1146-1149
Citation: Jw. Mouton et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF ACTIVITY OF CEFTAZIDIME DURING CONTINUOUS AND INTERMITTENT INFUSION, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 733-738
Authors:
DENHOLLANDER JG
HORREVORTS AM
VANGOOR MLPJ
VERBRUGH HA
MOUTON JW
Citation: Jg. Denhollander et al., SYNERGISM BETWEEN TOBRAMYCIN AND CEFTAZIDIME AGAINST A RESISTANT PSEUDOMONAS-AERUGINOSA STRAIN, TESTED IN AN IN-VITRO PHARMACOKINETIC MODEL, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 95-100
Authors:
KLUYTMANS JAJW
MOUTON JW
VANDENBERGH MFQ
MANDERS MJAAJ
MAAT APWM
WAGENVOORT JHT
MICHEL MF
VERBRUGH HA
Citation: Jajw. Kluytmans et al., REDUCTION OF SURGICAL-SITE INFECTIONS IN CARDIOTHORACIC SURGERY BY ELIMINATION OF NASAL CARRIAGE OF STAPHYLOCOCCUS-AUREUS, Infection control and hospital epidemiology, 17(12), 1996, pp. 780-785
Authors:
VANDEVENTER AJM
GOESSENS WHF
VANZEIJL JH
MOUTON JW
MICHEL MF
VERBRUGH HA
Citation: Ajm. Vandeventer et al., KINETICS OF ANTIMANNAN ANTIBODIES USEFUL IN CONFIRMING INVASIVE CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS, Microbiology and immunology, 40(2), 1996, pp. 125-131
Citation: Jw. Mouton et Aatmm. Vinks, IS CONTINUOUS-INFUSION OF BETA-LACTAM ANTIBIOTICS WORTHWHILE - EFFICACY AND PHARMACOKINETIC CONSIDERATIONS, Journal of antimicrobial chemotherapy, 38(1), 1996, pp. 5-15
Authors:
BRANDENBURG AH
VANBELKUM A
VANPELT C
BRUINING HA
MOUTON JW
VERBRUGH HA
Citation: Ah. Brandenburg et al., PATIENT-TO-PATIENT SPREAD OF A SINGLE STRAIN OF CORYNEBACTERIUM-STRIATUM CAUSING INFECTIONS IN A SURGICAL INTENSIVE-CARE UNIT, Journal of clinical microbiology, 34(9), 1996, pp. 2089-2094
Authors:
VINKS AATMM
MOUTON JW
TOUW DJ
HEIJERMAN HGM
DANHOF M
BAKKER W
Citation: Aatmm. Vinks et al., POPULATION PHARMACOKINETICS OF CEFTAZIDIME IN CYSTIC-FIBROSIS PATIENTS ANALYZED BY USING A NONPARAMETRIC ALGORITHM AND OPTIMAL SAMPLING STRATEGY, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1091-1097
Citation: Jg. Denhollander et al., ALTERATION OF POSTANTIBIOTIC EFFECT DURING ONE DOSING INTERVAL OF TOBRAMYCIN, SIMULATED IN AN IN-VITRO PHARMACOKINETIC MODEL, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 784-786
Citation: Jg. Denhollander et al., ENZYMATIC METHOD FOR INACTIVATION OF AMINOGLYCOSIDES DURING MEASUREMENT OF POSTANTIBIOTIC EFFECT, Antimicrobial agents and chemotherapy, 40(2), 1996, pp. 488-490